References
American Diabetes Association. (2011). Standards of medical care in diabetes—2011. Diabetes Care, 34(Suppl. 1), S11-S61. doi:10.2337/dc11-S011
American Diabetes Association. (2013). Standards of medical care in diabetes—2013. Diabetes Care, 36(Suppl. 1), S11-S66. doi:10.2337/dc13-S011
Clore, J. N., & Thurby-Hay, L. (2009). Glucocorticoid-induced hyperglycemia. Endocrine Practice, 15, 469-474. doi:10.4158/EP08331.RAR
Donihi, A. C., Raval, D., Saul, M., Korytkowski, M. T., & DeVita, M. A. (2006). Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocrine Practice, 12, 358-362.
Gogas, H., Shapiro, F., Aghajanian, C., Fennelly, D., Almadrones, L., Hoskins, W. J., & Spriggs, D. R. (1996). The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer. Gynecologic Oncology, 61, 22-26. doi:10.1006/gyno.1996.0090
Gonzalez-Gonzalez, J. G., Mireles-Zavala, L. G., Rodriguez-Gutierrez, R., Gomez-Almaguer, D., Lavalle-Gonzalez, F. J., Tamez-Perez, H. E., … Villarreal-Perez, J. Z. (2013). Hyperglycemia related to high-dose glucocorticoid use in noncritically ill patients. Diabetology and Metabolic Syndrome, 5, 18. doi:10.1186/1758-5996-5-18
Gosmanov, A. R., Goorha, S., Stelts, S., Peng, L., & Umpierrez, G. E. (2013). Management of hyperglycemia in diabetic patients with hematologic malignancies during dexamethasone therapy. Endocrine Practice, 19, 231-235. doi:10.4158/EP12256.OR
Gulliford, M. C., Charlton, J., & Latinovic, R. (2006). Risk of diabetes associated with prescribed glucocorticoids in a large population. Diabetes Care, 29, 2728-2729. doi:10.2337/dc06-1499
Guo, Y., Chandran, S., Palmer, J. L., & Bruera, E. (2011). The influence of hyperglycemia and other clinical variables on rehabilitation and hospital length of stay after neurosurgery in patients with cancer. American Journal of Hospice and Palliative Care, 28, 90-93. doi:10.1177/1049909110374455
Holtan, S. G., Pasquini, M., & Weisdorf, D. J. (2014). Acute GVHD: A bench to bedside update. Blood, 124, 363-373. doi:10.1182/blood-2014-01-514786
Inzucchi, S. E. (2006). Clinical practice. Management of hyperglycemia in the hospital setting. New England Journal of Medicine, 355, 1903-1911. doi:10.1056/NEJMcp060094
Iwamoto, T., Kagawa, Y., Naito, Y., Kuzuhara, S., & Kojima, M. (2004). Steroid-induced diabetes mellitus and related risk factors in patients with neurologic diseases. Pharmacotherapy, 24, 508-514.
Krone, C. A., & Ely, J. T. (2005). Controlling hyperglycemia as an adjunct to cancer therapy. Integrative Cancer Therapies, 4, 25-31. doi:10.1177/1534735404274167
Lee, S. Y., Kurita, N., Yokoyama, Y., Seki, M., Hasegawa, Y., Okoshi, Y., & Chiba, S. (2014). Glucocorticoid-induced diabetes mellitus in patients with lymphoma treated with CHOP chemotherapy. Supportive Care in Cancer, 22, 1385-1390. doi:10.1007/s00520-013-2097-8
Lleva, R. R., & Inzucchi, S. E. (2011). Hospital management of hyperglycemia. Current Opinion in Endocrinology, Diabetes, and Obesity, 18, 110-118. doi:10.1097/MED.0b013e3283447a6d
Lukins, M. B., & Manninen, P. H. (2005). Hyperglycemia in patients administered dexamethasone for craniotomy. Anesthesia and Analgesia, 100, 1129-1133. doi:10.1213/01.ane.0000146943.45445.55
Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., & Hirsch, I. B. (2009). American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care, 32, 1119-1131. doi:10.2337/dc09-9029
Morganstein, D. L., Tan, S., Gore, M., & Feher, M. D. (2012). Prevalence of diabetes in patients admitted to a cancer hospital. British Journal of Diabetes and Vascular Disease, 12, 178-180. doi:10.1177/1474651412459091
Oyer, D. S., Shah, A., & Bettenhausen, S. (2006). How to manage steroid diabetes in the patient with cancer. Journal of Supportive Oncology, 4, 479-483.
Patel, G. W., Roderman, N., Lee, K. A., Charles, M. M., Nguyen, D., Beougher, P., … Casteneda, E. (2009). Sliding scale versus tight glycemic control in the noncritically ill at a community hospital. Annals of Pharmacotherapy, 43, 1774-1780. doi:10.1345/aph.1M331
Pilkey, J., Streeter, L., Beel, A., Hiebert, T., & Li, X. (2012). Corticosteroid-induced diabetes in palliative care. Journal of Palliative Medicine, 15, 681-689.
Rock, C. L., Doyle, C., Demark-Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., … Gansler, T. (2012). Nutrition and physical activity guidelines for cancer survivors. CA: A Cancer Journal for Clinicians, 62, 242-274.
Rocque, G. B., Barnett, A. E., Illig, L. C., Eickhoff, J. C., Bailey, H. H., Campbell, T. C., … Cleary, J. F. (2013). Inpatient hospitalization of oncology patients: Are we missing an opportunity for end-of-life care? Journal of Oncology Practice, 9, 51-54. doi:10.1200/JOP.2012.000698
Romaguera, J. E., Fayad, L., Rodriguez, M. A., Broglio, K. R., Hagemeister, F. B., Pro, B., … Cabanillas, F. F. (2005). High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. Journal of Clinical Oncology, 23, 7013-7023. doi:10.1200/JCO.2005.01.1825
Ruutu, T., Juvonen, E., Remberger, M., Remes, K., Volin, L., Mattsson, J., … Marrow, T. (2014). Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: Long-term follow-up of a randomized study. Biology of Blood and Marrow Transplantation, 20, 135-138. doi:10.1016/j.bbmt.2013.10.014
Ryken, T. C., McDermott, M., Robinson, P. D., Ammirati, M., Andrews, D. W., Asher, A. L., … Kalkanis, S. N. (2010). The role of steroids in the management of brain metastases: A systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology, 96, 103-114. doi:10.1007/s11060-009-0057-4
Smiley, D., & Umpierrez, G. E. (2010). Management of hyperglycemia in hospitalized patients. Annals of the New York Academy of Science, 1212, 1-11. doi:10.1111/j.1749-6632.2010.05805.x
Trigg, M. E., & Higa, G. M. (2010). Chemotherapy-induced nausea and vomiting: Antiemetic trials that impacted clinical practice. Journal of Oncology Pharmacy Practice, 16, 233-244. doi:10.1177/1078155209354655
Umpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., & Montori, V. M. (2012). Management of hyperglycemia in hospitalized patients in non-critical care setting: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 97, 16-38. doi:10.1210/jc.2011-2098
van Raalte, D. H., Ouwens, D. M., & Diamant, M. (2009). Novel insights into glucocorticoid-mediated diabetogenic effects: Towards expansion of therapeutic options? European Journal of Clinical Investigation, 39, 81-93. doi:10.1111/j.1365-2362.2008.02067.x
Vu, K., Busaidy, N., Cabanillas, M. E., Konopleva, M., Faderl, S., Thomas, D. A., … Yeung, S. C. (2012). A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia. Clinical Lymphoma, Myeloma, and Leukemia, 12, 355-362. doi:10.1016/j.clml.2012.05.004